FDA approves world’s first cellular therapy for type-1 diabetes

by Mrigakshi Dixit – Interesting Engineering

Named Lantidra, it’s a cellular therapy developed using deceased donor pancreatic cells for the treatment of type 1 diabetes in adults.

Therapy suitable for patients with hypoglycemia

Type 1 diabetes makes the pancreas incapable of producing insulin. This is the first medication approved for those unable to regulate their blood sugar levels with standard insulin doses. This might result in significantly low blood sugar levels, known as hypoglycemia.

As per FDA, individuals may also develop “hypoglycemia unawareness” in some situations, when they are unable to perceive that their blood glucose is lowering. And this might worsen their health condition.

For those patients, Lantidra could be a potential treatment option to maintain their glucose levels.

Read More – Click Here